In the current era, transcatheter device closure is becoming the first-line therapy for anatomically feasible secundum atrial septal defect (ASD II). The overall complication rate is low, with the most common being device malposition/embolization and residual shunts. Cardiac perforations are rare, but atrial arrhythmias, thrombus formation, endocarditis, and atrioventricular valve regurgitation have been reported.
No takes yet. Share an insight, caveat, or question.
Said et al. (2022) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: